Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jay Tiongson

Clinical Cardiac Electrophysiology Mission Viejo, CA Medical Doctor

NPI 1609082312 CMS profile 299278

26800 Crown Valley Pkwy, Suite 250, Mission Viejo, CA 92691

Open in the dashboard

General payments

$43,177

525 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$30,699 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Jay Tiongson of Mission Viejo, CA is reported in the CMS Open Payments database as having received $43,177 across 525 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $30,699 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 72nd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,421 97
2024 General $7,596 102
2023 General $14,498 69
2022 General $6,868 75
2021 General $5,561 45
2020 General $315 10
2019 General $3,919 127

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jay Tiongson
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Jay Tiongson were reported at $4,421. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Jay Tiongson Clinical Cardiac Electrophysiology median Middle half National median
2019 $3,919 $2,361 $585–$8,260 $163
2020 $315 $993 $247–$4,351 $114
2021 $5,561 $1,185 $326–$4,739 $132
2022 $6,868 $2,073 $554–$6,789 $149
2023 $14,498 $2,568 $759–$8,159 $160
2024 $7,596 $2,557 $703–$7,403 $164
2025 $4,421 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $19,270 69 payments
  2. Abbott Laboratories $5,383 57 payments
  3. E.R. Squibb & Sons, L.L.C. $3,943 26 payments
  4. Medtronic, Inc. $3,210 67 payments
  5. Biosense Webster, Inc. $2,541 64 payments
  6. Boston Scientific Corporation $2,046 60 payments
  7. Acutus Medical, Inc. $1,414 9 payments
  8. CVRx, Inc. $1,220 9 payments
  9. Biotronik Inc. $1,211 13 payments
  10. Medtronic Vascular, Inc. $690 6 payments
  11. Other $2,251 145 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $16,200 487 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,104 12 payments
  3. Travel and Lodging $7,160 21 payments
  4. Consulting Fee $2,213 4 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $1,500 1 payment
Products named General payments · program years 2019–2025
  1. LifeVest $19,270 69 payments
  2. ELIQUIS Cardiovascular $3,021 23 payments
  3. ABSOLUTE PRO $2,500 2 payments
  4. Barostim Neo System $1,220 9 payments
  5. Carto 3 $1,091 32 payments
  6. AVEIR $898 7 payments
  7. MICRA $675 5 payments
  8. AFFERA MAPPING SYSTEM $655 14 payments
  9. ELIQUIS Cardiovascular;Metabolic Disease $580 51 payments
  10. PERCLOSE PROGLIDE $473 4 payments
  11. Other $9,005 328 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 44 drugs

Part D claims

5,145

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$2,261,301

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

45.7%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 1,225 $1,320,861
Multaq Dronedarone Hcl Brand 481 $607,214
Xarelto Rivaroxaban Brand 204 $218,873
Flecainide Acetate Generic 818 $32,608
Amiodarone Hcl Generic 311 $10,854
Dofetilide Generic 67 $10,697
Propafenone Hcl Er Propafenone Hcl Brand 54 $9,965
Corlanor Ivabradine Hcl Brand 11 $7,495
Diltiazem 12hr Er Diltiazem Hcl Brand 36 $5,633
Metoprolol Succinate Generic 369 $4,937

The 10 drugs with the highest cost, of 44 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 83 billing codes

Paid by Medicare

$653,976

Medicare's payments for the services billed

Medicare patients

993

Average age 79

Services billed

7,122

435 women, 558 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Arthritis 48%
Ischemic heart disease 43%
Heart failure 31%
Chronic kidney disease 30%
Diabetes 25%
Cancer 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $48
  • PFIZER INC. $44
$92 1,225 —
NURTEC ODT
  • PFIZER INC. $44
$44 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $27
$27 204 —
PAXLOVID
  • PFIZER INC. $17
$17 — —
Arcalyst
  • Kiniksa Pharmaceuticals International, plc $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

525 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record